Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$217,920
in 1 filing, $218K under 10b5-1 plans

Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RIKER LAUREN −$218K Senior Vice President, Finance sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Cross Shawn Chief Financial Officer Other disposition −9,210 $36.50 $336K 86,591
2026-11-17 Cross Shawn Chief Financial Officer Returned to the company −86,591 $36.50 $3.2M 0
2026-11-17 Cross Shawn Chief Financial Officer Returned to the company · Stock Option (Right to Buy) −150,000 0
2026-10-30 Cross Shawn Chief Financial Officer Shares withheld for taxes −9,540 $36.39 $347K 95,801
2026-04-23 Cross Shawn Chief Financial Officer Option exercise 10b5-1 +12,941 $16.45 $213K 118,282
2026-04-23 Cross Shawn Chief Financial Officer Sale 10b5-1 −12,941 $25.16 $326K 105,341
2026-04-23 Cross Shawn Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −12,941 150,000
2026-04-22 Cross Shawn Chief Financial Officer Option exercise 10b5-1 +1,500 $16.45 $25K 106,841
2026-04-22 Cross Shawn Chief Financial Officer Sale 10b5-1 −1,500 $25.01 $38K 105,341
2026-04-22 Cross Shawn Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −1,500 162,941
2026-04-21 Cross Shawn Chief Financial Officer Option exercise 10b5-1 +2,845 $16.45 $47K 108,186
2026-04-21 Cross Shawn Chief Financial Officer Sale 10b5-1 −2,845 $25.01 $71K 105,341
2026-04-21 Cross Shawn Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −2,845 164,441
2026-04-20 Cross Shawn Chief Financial Officer Option exercise 10b5-1 +7,714 $16.45 $127K 113,055
2026-04-20 Cross Shawn Chief Financial Officer Sale 10b5-1 −7,714 $25.14 $194K 105,341
2026-04-20 Cross Shawn Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −7,714 167,286
2026-02-11 Cross Shawn Chief Financial Officer Grant or award +49,091 105,341
2025-12-10 Cross Shawn Chief Financial Officer Option exercise 10b5-1 +9,104 $16.45 $150K 65,354
2025-12-10 Cross Shawn Chief Financial Officer Sale 10b5-1 −9,104 $25.14 $229K 56,250
2025-12-10 Cross Shawn Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −9,104 175,000

Page 1 of 2 · 27 trades